Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

United Sates Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Mar. 12, 2009 - 135 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Drug delivery devices
3.2 Needle-free Injections
3.3 Inhalation Systems
3.3.1 Metered Dose Inhaler
3.3.2 Dry powder inhaler
3.4 Infusion Systems
3.4.1 Infusion pumps
3.4.2 Syringe pumps
3.4.3 Disposable Infusion sets
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 United States Healthcare Trade Statistics
5 Regulation System
5.1 Regulation System
5.2 Medical Equipment Approval Process
5.2.1 Pre-market Approval Process
5.2.2 Intended use and Indications for use
5.2.3 Predicate Device
5.2.4 Safe and Effective
5.2.5 Other Category Devices
5.2.6 Post-Market Approval Process
5.2.7 Compliance and Enforcement
5.2.8 Registration Fee
5.2.9 Approval Time
6 Pricing and Reimbursement
6.1 Government Policies
6.2 Private Insurance
6.3 Diagnosis Related Groups (DRG)
7 Distribution Structure
7.1 Distribution Structure
8 Drug Delivery Devices In United States
8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015
8.3 Drug Delivery Devices, United States, Category Volume (Units), 2000-2015
8.4 Drug Delivery Devices, United States, Company Share (2006-2007)
9 Infusion Systems In United States
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, United States, Company Share (2006-2007)
10 Inhalation Systems In United States
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, United States, Company Share (2006-2007)
11 .Needle Free Injections In United States
11.1 Needle Free Injections Overall Revenue (2000-2015)
11.2 Needle Free Injections Overall Volume (2000-2015)
11.3 Needle Free Injections Average Price (2000-2015)
11.4 Needle Free Injections Distribution Share (2007-2008)
11.5 Needle Free Injections, United States, Company Share (2006-2007)
12 Overview of Key Companies in United States Drug Delivery Devices Market
12.1 AstraZeneca PLC Company Profile
12.1.1 Company Overview
12.2 GlaxoSmithKline plc Company Profile
12.2.1 Company Overview
12.3 Cardinal Health, Inc. Company Profile
12.3.1 Company Overview
12.3.2 Value Chain Analysis
12.3.2.1 Manufacturing
12.3.2.2 Product Development
12.3.2.3 Sales and Marketing
12.4 Baxter International Inc. Company Profile
12.4.1 Company Overview
12.4.2 Value Chain Analysis
12.4.2.1 Manufacturing
12.4.2.2 Product Development
12.4.2.3 Sales and Marketing
12.5 Hospira, Inc. Company Profile
12.5.1 Company Overview
12.5.2 Value Chain Analysis
12.5.2.1 Manufacturing
12.5.2.2 Product Development
12.5.2.3 Research and Development
12.5.2.4 Sales and Marketing
12.5.3 Hospira, Inc. Pipeline Products
12.5.3.1 Hospira, Inc. Pipeline Products by Equipment Type
12.5.3.2 Hospira, Inc. Pipeline Products by Development Stage
12.5.3.3 Hospira, Inc. Pipeline Products by Therapy Area
12.6 Boehringer Ingelheim GmbH Company Profile
12.6.1 Company Overview
12.6.2 Value Chain Analysis
12.6.2.1 Manufacturing
12.6.2.2 Product Development
12.6.2.3 Sales and Marketing
12.7 Novartis AG
12.7.1 Company Overview
12.8 Fresenius SE
12.8.1 Company Overview
12.9 Smiths Medical Company Profile
12.9.1 Company Overview
12.9.2 Value Chain Analysis
12.9.2.1 Manufacturing
12.9.2.2 Product Development
12.9.2.3 Sales and Marketing
12.10 Consort Medical plc Company Profile
12.10.1 Company Overview
12.10.2 Value Chain Analysis
12.10.2.1 Manufacturing
12.10.2.2 Product Development
12.10.2.3 Sales and Marketing
12.10.3 Consort Medical plc Pipeline Products
12.10.3.1 Consort Medical plc Pipeline Products By Equipment Type
12.10.3.2 Consort Medical plc Pipeline Products By Development Stage
12.10.3.3 Consort Medical plc Pipeline Products By Therapy Area
12.11 B. Braun Melsungen AG Company Profile
12.11.1 Company Overview
12.11.2 Value Chain Analysis
12.11.2.1 Manufacturing
12.11.2.2 Product Development
12.11.2.3 Research and Development
12.11.2.4 Sales and Marketing
12.12 Bioject Medical Technologies Inc.
12.12.1 Company Overview
12.12.2 Value Chain Analysis
12.12.2.1 Manufacturing
12.12.2.2 Product Development
12.12.2.3 Sales and Marketing
12.12.3 Bioject Medical Technologies Inc. Pipeline Products
12.12.3.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type
12.12.3.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage
12.12.3.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area
12.12.3.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials
12.12.3.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary
12.13 3M Company Profile
12.13.1 Company Overview
12.13.2 Value Chain Analysis
12.13.2.1 Manufacturing
12.13.2.2 Product Development
12.13.2.3 Sales and Marketing
12.14 Corium International, Inc. Company Profile
12.14.1 Company Overview
12.14.2 Corium International, Inc. Pipeline Products
12.14.2.1 Corium International, Inc. Pipeline Products By Equipment Type
12.14.2.2 Corium International, Inc. Pipeline Products By Development Stage
12.14.2.3 Corium International, Inc. Pipeline Products By Therapy Area
12.14.2.4 Corium International, Inc. Pipeline Products By News Summary
12.15 Aveva Drug Delivery Systems Company Profile
12.15.1 Company Overview
12.16 EFD, Inc. Company Profile
12.16.1 Company Overview
12.17 Inyx, Inc. Company Profile
12.17.1 Company Overview
12.18 IOMED, Inc. Company Profile
12.18.1 Company Overview
12.19 Liquidia Technologies, Inc. Company Profile
12.19.1 Company Overview
12.19.2 Liquidia Technologies, Inc. Pipeline Products
12.19.2.1 Liquidia Technologies, Inc. Pipeline Products by Equipment Type
12.19.2.2 Liquidia Technologies, Inc. Pipeline Products by Development Stage
12.19.2.3 Liquidia Technologies, Inc. Pipeline Products by Therapy Area
12.20 TheraJect, Inc. Company Profile
12.20.1 Company Overview
12.21 Verus Pharmaceuticals, Inc. Company Profile
12.21.1 Company Overview
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 Nicholas Piramal India Acquires MINRAD INTERNATIONAL
13.1.2 Access Pharmaceuticals Acquires MacroChem
13.1.3 Arkema Acquires Oxford Performance Materials
13.1.4 Endo Pharmaceuticals To Acquire Indevus Pharmaceuticals
13.1.5 QLT Acquires ForSight Newco II
13.2 Partnerships
13.2.1 Covidien Enters Into an Agreement with Depomed
13.2.2 MonoSol Rx Enters Into An Agreement With Midatech
13.2.3 Acusphere Signs An Agreement With Cephalon
13.2.4 Stallergenes Enters Into An Agreement With Catalent Pharma Solutions And The Medical House
14 Recent Developments
14.1 Strategy and Business Planning
14.1.1 Mar 03, 2009: Acusphere Reveals Cost Reduction Plans
14.1.2 Nov 25, 2008: Anika Therapeutics Terminates US Distribution Agreements With Artes Medical For ELEVESS
14.1.3 Nov 21, 2008: Vical Plans To Close Research Facility
14.2 Legal and Regulatory
14.2.1 Jan 21, 2009: 3M Settles Patent Lawsuit with Broadband Products
14.2.2 Jan 12, 2009: Kalur Law Files Lawsuits against Pain Pump and Local Anesthetic Makers
14.2.3 Jan 07, 2009: BD Settles Lawsuit with Ultimed
14.2.4 Oct 17, 2008: Brualdi Files Class Action Lawsuit against Elan
14.3 Government and Public Interest
14.3.1 Oct 07, 2008: RNA Molecules, Delivery System Improve Vaccine Responses, Effectiveness
14.3.2 Oct 03, 2008: FDA Updates Two 510(k) Marketing Guidances
14.3.3 Oct 02, 2008: Nanodiamond Drug Device Could Transform Cancer Treatment
14.4 Product News
14.4.1 Feb 13, 2009: VGX Pharmaceuticals Files Device Master File Amendment with the FDA for CELLECTRA Device
14.4.2 Jan 19, 2009: AeonClad Biomedical Utilizes AeonCoat Technology to the Drug Delivery and Medical Devices Markets
14.4.3 Jan 15, 2009: Teva Specialty Pharmaceuticals Donates ProAir HFA to Direct Relief International Help Economically Disadvantaged Asthma Sufferers Breathe Easier
14.4.4 Dec 16, 2008: CeloNova Announces FDA Clearance For Embozene Color-Advanced Microspheres Embolization Platform
14.4.5 Dec 04, 2008: FlowMedica Receives FDA Clearance For New Indication For The Benephit Infusion Systems
14.4.6 Nov 20, 2008: Trellis Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
14.4.7 Nov 13, 2008: Delsite Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies At The 2nd Vaccines Asia Conference
14.4.8 Nov 11, 2008: Philips’ Intelligent Pill Targets Drug Development And Treatment For Digestive Tract Diseases
14.4.9 Nov 03, 2008: Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial Of Epodure In Renal Anemia
14.4.10 Oct 17, 2008: Preliminary Phase I Safety Data For Preventive HIV Vaccine Delivered By Ichor’s TriGrid To Be Presented At AIDS Conference
14.4.11 Oct 15, 2008: Lilly Launches New FORTEO Delivery Device
15 Appendix
15.1 Global Markets Direct Research Methodology
15.2 Coverage
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panel Validation
15.8 Currency Conversion
15.9 Contact Us
15.10 Disclaimer
1.1 List of Tables
Table 1: United States Healthcare Expenditure, 2003-2010 18
Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003 19
Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003 19
Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003 19
Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004 20
Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004 21
Table 7: Total Number of Doctors in the United States, 2003-2010 24
Table 8: Number of Doctors by Specialty in the United States, 2003-2010 25
Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 26
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 27
Table 11: Total Hospitals in the United States, 2000-2004 27
Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004 28
Table 13: Number of Hospital Beds in the United States, 2000-2004 28
Table 14: Number of Hospital Beds by Range in the United States, 2000-2004 28
Table 15: United States Healthcare Trade Statistics, 2001-2006 29
Table 16: Medical Equipment Registration Fee in United States, 2007 36
Table 17: Medical Device Approval Time in United States, 2004 36
Table 18: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 41
Table 19: Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015 42
Table 20: Drug Delivery Devices, United States, Portfolio Analysis, 2000-2015 43
Table 21: Drug Delivery Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008 44
Table 22: Drug Delivery Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015 45
Table 23: Drug Delivery Devices, United States, Category Volume (Units), 2000-2015 46
Table 24: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2008 47
Table 25: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2008-2015 48
Table 26: Drug Delivery Devices, United States, Company Share by Revenue ($ mn), 2006-2007 49
Table 27: Infusion Systems, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 50
Table 28: Infusion Systems, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Table 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2000-2008 52
Table 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2008-2015 52
Table 31: Infusion Systems, United States, Average Price ($), Historic, 2000-2008 53
Table 32: Infusion Systems, United States, Average Price ($), Forecast, 2008-2015 53
Table 33: Infusion Systems, United States, Distribution Share by Revenue ($mn), 2007-2008 54
Table 34: Infusion Systems, United States, Company Share by Revenue ($ mn), 2006-2007 55
Table 35: Inhalation Systems, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 56
Table 36: Inhalation Systems, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 57
Table 37: Inhalation Systems, United States, Volume (Units) by Segment, Historic, 2000-2008 58
Table 38: Inhalation Systems, United States, Volume (Units) by Segment, Forecast, 2008-2015 59
Table 39: Inhalation Systems, United States, Average Price ($), Historic, 2000-2008 60
Table 40: Inhalation Systems, United States, Average Price ($), Forecast, 2008-2015 60
Table 41: Inhalation Systems, United States, Distribution Share by Revenue ($mn), 2007-2008 61
Table 42: Inhalation Systems, United States, Company Share by Revenue ($ mn), 2006-2007 62
Table 43: Needle Free Injections, United States, Revenue ($ mn), Historic, 2000-2008 63
Table 44: Needle Free Injections, United States, Revenue ($ mn), Forecast, 2008-2015 64
Table 45: Needle Free Injections, United States, Volume (Units), Historic, 2000-2008 65
Table 46: Needle Free Injections, United States, Volume (Units), Forecast, 2008-2015 66
Table 47: Needle Free Injections, United States, Average Price ($), Historic, 2000-2008 67
Table 48: Needle Free Injections, United States, Average Price ($), Forecast, 2008-2015 67
Table 49: Needle Free Injections, United States, Distribution Share by Revenue ($mn), 2007-2008 68
Table 50: Needle Free Injections, United States, Company Share by Revenue ($ mn), 2006-2007 69
Table 51: Hospira, Inc. Pipeline Products by Equipment Type 79
Table 52: Hospira, Inc. Pipeline Products By Development Stage 79
Table 53: Hospira, Inc. Pipeline Products By Therapy Area 79
Table 54: Consort Medical plc Pipeline Products by Equipment Type 87
Table 55: Consort Medical plc Pipeline Products By Development Stage 88
Table 56: Consort Medical plc Pipeline Products By Therapy Area 88
Table 57: Bioject Medical Technologies Inc. Pipeline Products by Equipment Type 94
Table 58: Bioject Medical Technologies Inc. Pipeline Products By Development Stage 95
Table 59: Bioject Medical Technologies Inc. Pipeline Products By Therapy Area 95
Table 60: Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials 95
Table 61: Bioject Medical Technologies Inc. Pipeline Products By News Summary 95
Table 62: Corium International, Inc. Pipeline Products by Equipment Type 99
Table 63: Corium International, Inc. Pipeline Products By Development Stage 99
Table 64: Corium International, Inc. Pipeline Products By Therapy Area 100
Table 65: Corium International, Inc. Pipeline Products By News Summary 100
Table 66: Liquidia Technologies, Inc. Pipeline Products by Equipment Type 103
Table 67: Liquidia Technologies, Inc. Pipeline Products By Development Stage 103
Table 68: Liquidia Technologies, Inc. Pipeline Products By Therapy Area 103
Table 69: Nicholas Piramal India Acquires MINRAD INTERNATIONAL 105
Table 70: Access Pharmaceuticals Acquires MacroChem 107
Table 71: Arkema Acquires Oxford Performance Materials 109
Table 72: Endo Pharmaceuticals To Acquire Indevus Pharmaceuticals 110
Table 73: QLT Acquires ForSight Newco II 112
Table 74: Covidien Enters Into An Agreement With Depomed 113
Table 75: MonoSol Rx Enters Into An Agreement With Midatech 114
Table 76: Acusphere Signs An Agreement With Cephalon 115
Table 77: Stallergenes Enters Into An Agreement With Catalent Pharma Solutions And The Medical House 116
Table 78: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: United States, Healthcare Expenditure by Source, 2003
Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007
Figure 3: Healthcare Expenses Segmentation by End User, 2003
Figure 4: Medical Equipment Approval Process in the United States, 2007
Figure 5: PMA Approval Process in the United States, 2007
Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007
Figure 7: Reimbursement Structure in the United States, 2007
Figure 8: Distribution Structure of Medical Equipment in the United States, 2006
Figure 9: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Figure 10: Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015
Figure 11: Drug Delivery Devices, United States, Portfolio Analysis, 2000-2015
Figure 12: Drug Delivery Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008
Figure 13: Drug Delivery Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 14: Drug Delivery Devices, United States, Category Volume (Units), 2000-2015
Figure 15: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2008
Figure 16: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2008-2015
Figure 17: Drug Delivery Devices, United States, Company Share (%), 2007
Figure 18: Infusion Systems, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 19: Infusion Systems, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 20: Infusion Systems, United States, Company Share (%), 2007
Figure 21: Inhalation Systems, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 22: Inhalation Systems, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 23: Inhalation Systems, United States, Volume (Units) by Segment, Historic, 2000-2008
Figure 24: Inhalation Systems, United States, Volume (Units) by Segment, Forecast, 2008-2015
Figure 25: Inhalation Systems, United States, Company Share (%), 2007
Figure 26: Needle Free Injections, United States, Revenue ($ mn), Historic, 2000-2008
Figure 27: Needle Free Injections, United States, Revenue ($ mn), Forecast, 2008-2015
Figure 28: Needle Free Injections, United States, Volume (Units), Historic, 2000-2008
Figure 29: Needle Free Injections, United States, Volume (Units), Forecast, 2008-2015
Figure 30: Needle Free Injections, United States, Company Share (%), 2007
Figure 31: Cardinal Health, Inc. Value Chain Analysis
Figure 32: Baxter International Inc. Value Chain Analysis
Figure 33: Hospira, Inc. Value Chain Analysis
Figure 34: Boehringer Ingelheim GmbH Value Chain Analysis
Figure 35: Smiths Medical Value Chain Analysis
Figure 36: Consort Medical plc Value Chain Analysis
Figure 37: B. Braun Melsungen AG Value Chain Analysis
Figure 38: Bioject Medical Technologies Inc., Value Chain Analysis
Figure 39: 3M Company Value Chain Analysis
Figure 40: Global Markets Direct Methodology

Abstract

United Sates Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the USA drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in USA

Scope
  • The report provides drug delivery devices information broken down into detailed categories and segments in United States.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the drug delivery devices market in United States.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009